Skip to main content
Top
Published in: Clinical Rheumatology 9/2016

01-09-2016 | Original Article

Discrepancies in how the impact of gout is assessed in outcomes research compared to how health professionals view the impact of gout, using the lens of the International Classification of Functioning, Health and Disability (ICF)

Authors: Eveline M. Kool, Marieke J. Nijsten, Annelies E. van Ede, Tim L. Jansen, William J. Taylor

Published in: Clinical Rheumatology | Issue 9/2016

Login to get access

Abstract

The International Classification of Functioning, Disability and Health (ICF) provides a common language to understand what health means. An ICF core set, a list of ICF categories affected by a certain disease, is useful to objectify the content validity of a health status measurement. This study aims to identify the potential items of a gout specific ‘ICF core set’. A three-round Delphi exercise was conducted, using web-based questionnaires. Health professionals, specialized in gout, nominated and subsequently rated the relevance of life areas divided into ICF categories. Agreement was determined by using the UCLA/RAND criteria. Simultaneously, a systematic review of gout measure outcomes was conducted. The results of these studies were compared using the second level of the ICF categories. In the Delphi study, consensus was found for 136 relevant ICF categories. The literature study extracted 134 different ICF categories in 149 articles. Three hundred and ten were non-defined outcomes. A large number of ICF categories were deemed to be relevant for people with gout. Only 29.7 % (19/64) of the level 2 categories, deemed to be relevant by health professionals, had been assessed as relevant in at least 5 % of gout outcome studies. Conversely, 70 % (19/27) of level 2 ICF categories assessed in at least 5 % of outcome studies were deemed relevant by health professionals. These ICF codes, which are found relevant in both studies, should be considered as mandatory in further research to a validated and practical core set of ICF categories. Published gout outcomes research fails to evaluate many life areas that are thought relevant by health professionals.
Appendix
Available only for authorised users
Literature
2.
go back to reference Taylor WJ, Grainger R (2012) Clinical features of gout. In: Terkeltaub R, ed. Gout and other crystal arthropathies, Firstth edn. Elsevier Saunders, Philadelphia PA Taylor WJ, Grainger R (2012) Clinical features of gout. In: Terkeltaub R, ed. Gout and other crystal arthropathies, Firstth edn. Elsevier Saunders, Philadelphia PA
3.
go back to reference Taylor WJ (2013) Measurement of outcome in gout. Indian J Rheumatol 8:S11–S15CrossRef Taylor WJ (2013) Measurement of outcome in gout. Indian J Rheumatol 8:S11–S15CrossRef
4.
go back to reference Alvarez_Hernandez E, Pelaez_Ballestas I, Vazquez_Mellado J et al (2008) Validation of the Health Assessment Questionnaire disability index in patients with gout. Arthritis Rheum 59:665–669CrossRefPubMed Alvarez_Hernandez E, Pelaez_Ballestas I, Vazquez_Mellado J et al (2008) Validation of the Health Assessment Questionnaire disability index in patients with gout. Arthritis Rheum 59:665–669CrossRefPubMed
5.
go back to reference Taylor WJ, Colvine K, Gregory K, Collis J, McQueen FM, Dalbeth N (2008) The Health Assessment Questionnaire Disability Index is a valid measure of physical function in gout. Clin Exp Rheumatol 26:620–626PubMed Taylor WJ, Colvine K, Gregory K, Collis J, McQueen FM, Dalbeth N (2008) The Health Assessment Questionnaire Disability Index is a valid measure of physical function in gout. Clin Exp Rheumatol 26:620–626PubMed
6.
go back to reference Colwell HH, Hunt BJ, Pasta DJ et al (2006) Gout Assessment Questionnaire: initial results of reliability, validity and responsiveness. Int J Clin Pract 60:1210–1217CrossRefPubMed Colwell HH, Hunt BJ, Pasta DJ et al (2006) Gout Assessment Questionnaire: initial results of reliability, validity and responsiveness. Int J Clin Pract 60:1210–1217CrossRefPubMed
7.
go back to reference Singh JA, Taylor WJ, Simon LS et al (2011) Patient-reported outcomes in chronic gout: a report from OMERACT 10. J Rheumatol 38:1452–1457CrossRefPubMed Singh JA, Taylor WJ, Simon LS et al (2011) Patient-reported outcomes in chronic gout: a report from OMERACT 10. J Rheumatol 38:1452–1457CrossRefPubMed
8.
go back to reference World Health Organisation (2002) Towards a common language for functioning, disability and health: ICF. World Health Organisation, Geneva World Health Organisation (2002) Towards a common language for functioning, disability and health: ICF. World Health Organisation, Geneva
9.
go back to reference Coenen M, Cieza A, Stamm TA, Amann E, Kollerits B, Stucki G (2006) Validation of the International Classification of Functioning, Disability and Health (ICF) core set for rheumatoid arthritis from the patient perspective using focus groups. Arthritis Res Ther 8:R84CrossRefPubMedPubMedCentral Coenen M, Cieza A, Stamm TA, Amann E, Kollerits B, Stucki G (2006) Validation of the International Classification of Functioning, Disability and Health (ICF) core set for rheumatoid arthritis from the patient perspective using focus groups. Arthritis Res Ther 8:R84CrossRefPubMedPubMedCentral
10.
go back to reference Cieza A, Stucki G, Weigl M, et al. ICF core sets for low back pain. J Rehabil Med 2004:69–74 Cieza A, Stucki G, Weigl M, et al. ICF core sets for low back pain. J Rehabil Med 2004:69–74
11.
go back to reference Dreinhofer K, Stucki G, Ewert T, et al. ICF core sets for osteoarthritis. J Rehabil Med 2004:75–80 Dreinhofer K, Stucki G, Ewert T, et al. ICF core sets for osteoarthritis. J Rehabil Med 2004:75–80
12.
go back to reference Boonen A, Braun J, van der Horst Bruinsma IE, et al. ASAS/WHO ICF core sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health. Ann Rheum Dis;69:102–07 Boonen A, Braun J, van der Horst Bruinsma IE, et al. ASAS/WHO ICF core sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health. Ann Rheum Dis;69:102–07
13.
go back to reference Cieza A, Ewert T, Ustun TB, Chatterjee S, Kostanjsek N, Stucki G (2004) Development of ICF core sets for patients with chronic conditions. J Rehabil Med 44:9–11PubMed Cieza A, Ewert T, Ustun TB, Chatterjee S, Kostanjsek N, Stucki G (2004) Development of ICF core sets for patients with chronic conditions. J Rehabil Med 44:9–11PubMed
14.
go back to reference Kiltz U, van der Heijde D, Boonen A et al (2015) Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS. Ann Rheum Dis 74:830–835CrossRefPubMed Kiltz U, van der Heijde D, Boonen A et al (2015) Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS. Ann Rheum Dis 74:830–835CrossRefPubMed
15.
go back to reference Cieza A, Geyh S, Chatterji S, Kostanjsek N, Ustun B, Stucki G (2005) ICF linking rules: an update based on lessons learned. J Rehabil Med 37:212–218CrossRefPubMed Cieza A, Geyh S, Chatterji S, Kostanjsek N, Ustun B, Stucki G (2005) ICF linking rules: an update based on lessons learned. J Rehabil Med 37:212–218CrossRefPubMed
16.
go back to reference Fitch K, Bernstein SJ, Aguilar MD et al (2001) The RAND/UCLA appropriateness method user’s manual. RAND, Santa Monica, CA Fitch K, Bernstein SJ, Aguilar MD et al (2001) The RAND/UCLA appropriateness method user’s manual. RAND, Santa Monica, CA
17.
go back to reference Diaz_Torne C, Pou MA, Castellvi I, Corominas H, Taylor WJ (2014) Concerns of patients with gout are incompletely captured by OMERACT endorsed domains of measurement for chronic gout studies. J Clin Rheumatol 20:138–140CrossRefPubMed Diaz_Torne C, Pou MA, Castellvi I, Corominas H, Taylor WJ (2014) Concerns of patients with gout are incompletely captured by OMERACT endorsed domains of measurement for chronic gout studies. J Clin Rheumatol 20:138–140CrossRefPubMed
18.
go back to reference Lindsay K, Gow P, Vanderpyl J, Logo P, Dalbeth N (2011) The experience and impact of living with gout: a study of men with chronic gout using a qualitative grounded theory approach. J Clin Rheumatol 17:1–6CrossRefPubMed Lindsay K, Gow P, Vanderpyl J, Logo P, Dalbeth N (2011) The experience and impact of living with gout: a study of men with chronic gout using a qualitative grounded theory approach. J Clin Rheumatol 17:1–6CrossRefPubMed
Metadata
Title
Discrepancies in how the impact of gout is assessed in outcomes research compared to how health professionals view the impact of gout, using the lens of the International Classification of Functioning, Health and Disability (ICF)
Authors
Eveline M. Kool
Marieke J. Nijsten
Annelies E. van Ede
Tim L. Jansen
William J. Taylor
Publication date
01-09-2016
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 9/2016
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-016-3325-7

Other articles of this Issue 9/2016

Clinical Rheumatology 9/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.